Successful management of acute thromboembolic disease complicated with heparin induced thrombocytopenia type II (HIT II): A case series

Thrombosis Journal

Volumn 6, Issue , 2008, Pages

  Serasli, Eva ^a   Antoniadou, Maria ^a   Tsara, Venetia ^a   Kalpakidis, Vassilis ^a   Megalopoulos, Angelos ^a   Trellopoulos, George ^a   Papaioannou, Georgia ^b   Christaki, Pandora ^a  

^a G PAPANICOLAOU HOSPITAL   (Greece)

^b PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; FONDAPARINUX; HEPARIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE RESPIRATORY FAILURE; ADULT; ANAMNESIS; ANTIBODY TITER; ARTHROPLASTY; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BOLUS INJECTION; BRAIN HEMORRHAGE; CASE REPORT; CASE STUDY; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME IMMUNOASSAY; FEMALE; FEMORAL VEIN; HEART RIGHT VENTRICLE FAILURE; HEPARIN INDUCED THROMBOCYTOPENIA; HOMOCYSTINURIA; HUMAN; ILIAC VEIN; INFERIOR CAVA VEIN; LONG TERM CARE; LUNG EMBOLISM; MALE; POPLITEAL VEIN; RECOMMENDED DRUG DOSE; RECURRENCE RISK; RISK FACTOR; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THROMBOCYTE COUNT; THROMBOEMBOLISM; THROMBOPHILIA; VENA CAVA FILTER;

EID: 47949130963     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-6-9     Document Type: Article

References (22)

1. Warkentin TE Greinacher A Heparin-induced thrombocytopenia: Recognition, treatment and prevention: The seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 2004, 126 (3 Suppl):311S-337S. 10.1378/ chest.126.3_suppl.311S 15383477
2. Spinler S New concepts in Heparin-Induced Thrombocytopenia: Diagnosis and management J Thromb Thrombolysis 2006, 21(1):17-21. 10.1007/ s11239-006-5571-z 16475037
3. Pravinkumar E Webster NR HIT/HITT and alternative anticoagulation: Current concepts Br J Anaesth 2003, 90:676-685. 10.1093/bja/aeg063 12697598
4. Kelton JG Heparin-induced thrombocytopenia: An overview Blood Rev 2002, 16:77-80. 10.1054/blre.2001.0189 11914002
5. Hassell K The management of patients with Heparin-Induced Thrombocytopenia who require anticoagulant therapy Chest 2005, 127:1S-8S. 10.1378/chest.127.2_suppl.1S 15706025
6. Nand S Wong W Yuen B Yetter A Schmulbach E Gross Fisher S Heparin-induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors and clinical outcomes in 108 consecutive patients treated in a single institution Am J Hematol 1997, 56:12-16. 10.1002/ (SICI)1096-8652(199709)56:1<12::AID-AJH3>3.0.CO;2-5 9298861
7. Kuo KH Kovacs MJ Fondaparinux: A potential new therapy for HIT Hematology 2005, 10(4):271-275. 10.1080/10245330500093492 16085538
8. Wallis DE Workman DL Lewis BE Steen L Pifarre R Moran JF Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia Am J Med 1999, 106:629-635. 10.1016/ S0002-9343(99)00124-2 10378620
9. Levine RL McCollum D Hursting MJ How frequently is venous thromboembolism in heparin-induced thrombocytopenia? Chest 2006, 130(3):681-7. 10.1378/chest.130.3.681 16963663
10. Keeling D Davidson S Watson H The management of heparin-induced thrombocytopenia Br J Haematol 2006, 133:259-269. 10.1111/ j.1365-2141.2006.06018.x 16643427
11. Efird LE Kockler DR Fondaparinux for Thromboembolic Treatment and Prophylaxis of Heparin-Induced Thrombocytopenia Ann Pharmacother 2006, 40:1383-7. 10.1345/aph.1G738 16788093
12. Warkentin TE Maurer BT Aster RH Heparin-Induced Thrombocytopenia Associated with Fondaparinux N Engl J Med 2007, 356:2653-2654. 10.1056/ NEJMc070346 17582083
13. Rota E Bazzan M Fantino G Fondaparinux-related thrombocytopenia in a previous low-molecular-weight-heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT) Thromb Haemost 2008, 99(4):779-81. 18392338
14. Savi P Chong BH Greinacher A Gruel Y Kelton JG Warkentin TE Eichler P Meuleman D Petitou M Herault JP Cariou R Herbert JM Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: A blinded comparative multicenter study with unfractionated heparin Blood 2005, 105:139-44. 10.1182/blood-2004-05-2010 15388575
15. Warkentin TE Cook RJ Marder VJ Sheppard JA Moore JC Eriksson BI Greinacher A Kelton JG Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin Blood 2005, 106:3791-3796. 1895104 16109780 10.1182/blood-2005-05-1938
16. Büller HR Davidson BL Decousus H Gallus A Gent M Piovella F Prins MH Raskob G Berg-Segers van den AE Cariou R Leeuwenkamp O Lensing AW Matisse Investigators Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism N Engl J Med 2003, 349:1695-702. 10.1056/NEJMe038112 14585937
17. Büller HR Davidson BL Decousus H Gallus A Gent M Piovella F Prins MH Raskob G Segers AE Cariou R Leeuwenkamp O Lensing AW Matisse Investigators Fondaparinux or enoxaparin for the initial treatment of deep venous thrombosis. A randomized trial Ann Intern Med 2004, 140:867-73. 15172900
18. Emig U Meyer T Buchwald AB Successful lysis of iliofemoral and inferior vena cava thrombi in heparin-induced type-II thrombocytopenia Dtsch Med Wochenschr 1997, 122(31-32):965-8. 9280716
19. Grassi CJ Swan TL Cardella JF Meranze SG Oglevie SB Omary RA Roberts AC Sacks D Silverstein MI Towbin RB Lewis CA Society of Interventional Radiology Standards of Practice Committee Quality Improvement Guidelines for Percutaneous Permanent Inferior Vena Cava Filter Placement for the Prevention of Pulmonary Embolism J Vasc Interv Radiol 2003, 14:S271-5. 14514832
20. Augustinos P Ouriel K Invasive Approaches to Treatment of Venous Thromboembolism Circulation 2004, 110(9 Suppl 1):I27-34. 10.1161/ 01.CIR.0000140900.64198.f4 15339878
21. Patel SH Patel R Inferior Vena Cava Filters for Recurrent Thrombosis Tex Heart Inst J 2007, 34(2):187-194. 1894721 17622366
22. D'Angelo A Valle PD Fattorini A Luciano C Disappearance of anti-PF4/ heparin antibodies under prolonged fondaparinux administration in a patient with DVT associated with LMWH-induced thrombocytopenia Thromb Haemost 2006, 95(3):573-5. 16525590